Clinical assessment tools have important roles in the identification of concussion as well as the characterization of problematic residual symptoms and impairments. Research into blood-based biomarkers such as GFAP, UCH-L1, tau, neurofilament light, and S100B aims to improve the rapid diagnosis and risk stratification of adult concussion, but no single marker is yet accurate enough for standalone clinical use....
No immediate practice change warranted from this review alone; it serves as a useful reference for audiologists and vestibular specialists selecting evidence-based tools to assess adult concussion patients.
A clear map of validated adult concussion assessment tools supports more consistent and evidence-informed clinical decision-making across audiology and neuro-vestibular practice.
- 01Reviews the breadth of clinical tools available for adult concussion identification and symptom characterization.
- 02Addresses residual impairments including vestibular and cognitive symptoms relevant to audiologists.
- 03Published in Seminars in Pediatric Neurology (2026), despite the adult focus of this specific article.
- 04Provides a structured overview useful for clinicians building or updating concussion protocols.
- 05Complements pediatric-focused articles in the same journal issue.
Multiple clinical assessment tools can identify concussion and characterize residual symptoms and impairments in adults.
studysupported- PMID
- 42264870
- DOI
- 10.1016/j.spen.2026.101268.
- Journal
- Seminars in Pediatric Neurology
- Publication type
- review
- Evidence level
- 5
- Population
- Adults with concussion or residual post-concussion symptoms
- Intervention
- Clinical assessment tools for concussion
Primary outcomes
Identification of concussion in adults; Characterization of residual symptoms and impairments post-concussion